We were fortunate to host our 2020 Genome Editing Symposium: Innovations and Improvements virtually last year with excellent seminars well worth watching over and over! Check out any one of our 2020 speakers’ seminar videos below. Please feel free to reach out to us or any of our speakers if you have any questions about the 2020 presentations.
Dr. Markita Landry
In this seminar, Dr. Lanadry from U.C. Berkeley delivers on exciting prospects for using nanoparticles and DNA nanostructures for the delivery of gene editing and gene silencing cargo across monocots and dicots. Currently, the Landry lab is pioneering host-independent delivery methods that may allow for the circumvention of laborious tissue culture and regeneration practices. Dr. Landry details a multitude of nanoparticles currently being experimented with for the delivery of gene editing cargo for optimal editing efficiency.
Dr. Yinong Yang
Dr. Yinong Yang’s lab at Penn State and the focus of this seminar investigates CRISPR/Cas genome editing tools for breeding and disease management in rice. Here, Dr. Yang discusses the principles of CRISPR/Cas and the design of gene editing systems using software (e.g., CRISPR-P) developed by his lab for targeted mutagenesis and the reduction of off-target effects. Dr. Yang also discusses the application of gene editing and adenine base editors for functional genomics analyses in plants.
Dr. Christine Shyu
Bayer Crop Science
Dr. Christine Shyu represented Bayer Crop Science at our 2020 Symposium to explain in detail the strategy and transition of gene edited products from idea to market. Importantly, Dr. Shyu highlights the technical details required for product development and crucial things to consider when designing gene-edited crops for best production outcomes. Finally, Dr. Shyu discusses regulatory standards of gene edited products, the distinction of GMOs and non-GMOs across the world, and all of the grey area in between.
Dr. Kevin Esfelt
Massachusetts Institute of Technology
In this seminar, Dr. Kevin Esfelt of MIT shares 4 compelling stories on the application of gene editing technologies to address ongoing ecological and human health related concerns: 1. ecological editing of wild rodent populations using various daisy-chain gene drive systems, 2. a systemic exploration of molecular evolution in phage-host systems using robotics, 3. optimizing virus resistance in an animals using elaborate array systems, and 4. in keeping with relevance of SARS-COV-2 and zoonotic diseases, using gene editing and . de novo synthesis approaches to model and predict future outbreaks